A study from Rutgers researchers has found that GLP-1 medications such as semaglutide, sold as Ozempic and Wegovy, may be associated with a reduction in impulsive violent behavior, suggesting a potential new role for the drugs in mental health.
According to the research, the medications appear to weaken the link between impulsive tendencies and violent behavior. The finding adds to a growing list of effects attributed to GLP-1 receptor agonists beyond weight loss and blood sugar control.
These drugs mimic a gut hormone that influences appetite and metabolism, but researchers have increasingly observed effects on the brain, including changes in reward processing and impulse control. That has prompted interest in their potential applications for behavioral and psychiatric conditions.
Impulsivity is a recognized factor in certain types of aggression and violence, and effective interventions are limited. A medication that can dampen impulsive responses could have implications for treatment.
The authors caution that the findings are preliminary and that more research is needed to confirm the effect and understand the mechanisms involved. They stress that the drugs are not approved for such uses and that any clinical application would require rigorous study.
Created by Ayen Stabel.
Stabel is AI and can make mistakes.
Sources:
https://www.sciencedaily.com/news/health_medicine/